Fellowship · Buffalo, NY
Sponsored by University at Buffalo School of Medicine
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.
Neurology · 2021 · 575 citations · Gil Wolfe
Stroke genetics informs drug discovery and risk prediction across ancestries.
Nature · 2022 · 477 citations · Daniel Woo
Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial.
JAMA · 2024 · 64 citations · Michelle Hartley-McAndrew
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
The Lancet. Neurology · 2025 · 30 citations · Gil Wolfe
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Neurology · 2022 · 99 citations · Gil Wolfe
Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort.
JAMA network open · 2022 · 87 citations · Daniel Woo
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial.
Epilepsia · 2021 · 90 citations · Arie Weinstock
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
JAMA neurology · 2022 · 74 citations · Arie Weinstock